Drug Type AAV based gene therapy |
Synonyms GS 1168, GS1168 |
Target |
Action modulators |
Mechanism PAH modulators(Phenylalanine hydroxylase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
RegulationOrphan Drug (United States) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Phenylketonurias | Phase 1 | China | 31 Dec 2025 |





